Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • MUSE Microscopy Appoints PathGroup Founder and Co-Chairman Dr. Ben W. Davis to Board of Directors World News
  • Whip-It! Motif Torch Named New York Times Wirecutter Pick Business
  • How did Feygin meet Arestovich?  How will Feygin return to Russia?  Interview with Ramina Eshakzai.
    How did Feygin meet Arestovich? How will Feygin return to Russia? Interview with Ramina Eshakzai. World News
  • Strategies For Global Mining Waste Management Market Players In 2022-2031 Market Forecast Period World News
  • New Report Examines Pricing, Ratings, and Precious Metals IRA Services Business
  • Day 402: war diaries w/Former Advisor to Ukraine President, Intel Officer  @arestovych  & #Feygin
    Day 402: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Pet Food Market Share Worth $ 133,430.9 Million By 2031 With CAGR Of 4.6% Business
  • Analyzing Growth Drivers, Share, Segments, and Emerging Trends World News

IF YOUR FINANCIAL ADVISOR RECOMMENDED NOVO NORDISK A/S INVESTMENTS PLEASE CONTACT KT LAW

Posted on February 14, 2025 By NewsEditor

If you suffered losses in Novo Nordisk S/A, Contact KT Law

KlaymanToskes Investigates on Behalf of Investors Who Were Recommended Novo Nordisk A/S Investments By Their Broker/Advisor

Novo Nordisk S/A (NYSE:NVO)

NEW YORK, NY, UNITED STATES, February 4, 2025 /EINPresswire.com/ — National investment loss and securities lawyers KlaymanToskes issues an important notice to investors who suffered significant losses in Novo Nordisk S/A (NYSE: NVO). The law firm urges customers of brokerage firms and financial advisors who suffered investment losses in excess of $100,000 in Novo Nordisk S/A to contact the firm immediately at 888-997-9956. Investors with self-directed accounts who did not rely on the advice of a financial advisor are not eligible for our representation.

KlaymanToskes is investigating brokerage firms and financial advisors that recommended investments in Novo Nordisk to their customers. On December 20, 2024, Novo Nordisk disclosed that only 57.3% of patients in its REDEFINE-1 trial were able to remain on the highest CagriSema dose, compared to 82.5% for cagrilintide and 70.2% for semaglutide. Following this news, Novo Nordisk’s stock plunged nearly 18%.

Our investigation has led the law firm to believe that investment firms and their financial advisors may have failed to act in the best interest of their customers, and misrepresented the risk-factors related to investments in Novo Nordisk S/A, in addition to failing to conduct due diligence on Novo Nordisk’s investment offering, leading to unsuitable recommendations.

Financial advisors and their firms may be held liable for any losses incurred by their customers in the event of failure to act in the best interest of the customer, unsuitable investment recommendations, misrepresentations or omissions of material facts, and/or an overconcentration of the customer’s portfolio in one particular investment, class, or market sector. Further, financial professionals and their firms cannot disregard a customer’s risk-tolerance when making investment recommendations.

Depending on your circumstances, you may be entitled to recover your losses through FINRA arbitration, which may result in a greater and additional recovery to solely participating and waiting for any recovery in any class action lawsuit.

Investors who suffered losses over $100,000 in Novo Nordisk S/A are encouraged to contact attorney Steven D. Toskes at (888) 997-9956 or by email at [email protected] in furtherance of our investigation. Investors with self-directed accounts who did not rely on the advice of a financial advisor are not eligible for our representation.

About KlaymanToskes

KlaymanToskes is a leading national securities law firm which practices exclusively in the field of securities arbitration and litigation on behalf of retail and institutional investors throughout the world in large and complex securities matters. The firm has recovered over $250 million in FINRA arbitrations and over $350 million in other securities litigation matters. KlaymanToskes has office locations in California, Florida, New York, and Puerto Rico.

Contact

Steven D. Toskes, Esq.
KlaymanToskes, P.A.
+1 888-997-9956
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

February 04, 2025, 15:57 GMT


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as IF YOUR FINANCIAL ADVISOR RECOMMENDED NOVO NORDISK A/S INVESTMENTS PLEASE CONTACT KT LAW

Business

Post navigation

Previous Post: Analyzing Growth Drivers, Market Share, Segments, Trends
Next Post: Saudia’s Chief Guest Experience Officer, Mr. Rossen Dimitrov, to Deliver Keynote at Airport Expansion Conference 2025

Related Posts

  • Lucata Corporation Announces Frank Brown as Chief Financial Officer Business
  • Atlanta photographer Ron Sherman’s book — Witness, A Photographic Essay of Humor and Heart — is available for purchase
    Atlanta photographer Ron Sherman’s book — Witness, A Photographic Essay of Humor and Heart — is available for purchase Business
  • Sean McQuaid Wins Best Attorney for Tampa Bay’s Best of the Bay Business
  • A Game-Changing Portable Peeing Device for Men Business
  • Radix to launch a new version of its Android TV Manager at CES 2024 Business
  • NinjaTech AI Unveils World’s Fastest Deep Research: Revolutionizing AI-Powered Information Analysis Business
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Atenolol Market Outlook Report Including Segment Analysis and Strategic Industry InsightsNovember 18, 2026
  • Abdullah Al Junayed Releases Open Research Dataset on Machine FatigueNovember 18, 2026
  • The At-Home Genetic Testing Market Is Projected to Grow at a 15.5% CAGR by 2030November 17, 2026
  • MESSCAN Launches TC25 Compact Laser Distance Sensor for OEM Optical and Electro-Optical IntegrationNovember 17, 2026
  • The Assisted Reproductive Technology Market is to grow at a CAGR of 8.9%, reaching a value of $56.96 billion by 2030.November 16, 2026
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Celebrating International Women’s Day – United States Department of State World News
  • The Cultural Significance of Sedona’s Sacred Land Aviation
  • Warp Solution to Unveil AI Tracking and Beamforming-Based Wireless Power Transfer Platform at CES 2026 Business
  • ERP Advisors Group and Acumatica Empower Businesses to Migrate to the Cloud Business
  • Pyra AI Launches Lead Seeker, an AI-Powered Prospecting Workspace for Revenue Teams Business
  • War Day 290: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 290: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Global Data Systems Appoints Doug Pickle as President, Driving Strategic Growth Business
  • Facilities Advisors Announces Maintenance Planning for Timeshare Resorts Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2026 195 News. All Rights Reserved by Coolaser

Powered by .